
BioVaxys and Sona Nanotech Enter Research Collaboration
BioVaxys Technology Corp. and Sona Nanotech Inc. have announced a research collaboration to develop innovative cancer therapeutics by combining BioVaxys’ DPX immune-educating platform with Sona’s targeted hyperthermia therapy (THT). THT uses infrared light …